Mei‐ying W. Yu

Center for Biologics Evaluation and Research — United States

Medicine · Health Sciences

16h-index970citations28works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(13), Hepatitis B Virus Studies(10), Parvovirus B19 Infection Studies(7), Dermatological and COVID-19 studies(5), Prenatal Screening and Diagnostics(4)

Publications28 total

Impact of chemiluminescent enzyme immunoassay screening for human parvovirus <scp>B</scp>19 antigen in <scp>J</scp>apanese blood donors
Transfusion·2012· 23 cited
Persistent Growth of a Human Plasma-Derived Hepatitis C Virus Genotype 1b Isolate in Cell Culture
PLoS Pathogens·2010· 13 citedOpen Access
Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples
Transfusion·2010· 50 citedOpen Access
West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States
Emerging infectious diseases·2009· 39 citedOpen Access
A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion
Blood·2009· 81 citedOpen Access
A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations
Virology Journal·2008· 16 citedOpen Access
Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma
Proceedings of the National Academy of Sciences·2007· 129 citedOpen Access
Parvovirus B19 DNA in Factor VIII concentrates: effects of manufacturing procedures and B19 screening by nucleic acid testing
Transfusion·2007· 32 cited
Quantification of hepatitis B virus genomes and infectivity in human serum samples
Transfusion·2006· 43 cited
Measles‐Virus–Neutralizing Antibodies in Intravenous Immunoglobulins
The Journal of Infectious Diseases·2006· 58 citedOpen Access
Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees
Proceedings of the National Academy of Sciences·2006· 28 citedOpen Access
International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States
Biologicals·2006· 6 cited
Parvovirus B19 transmission by a high‐purity factor VIII concentrate
Transfusion·2005· 63 cited
Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma
Proceedings of the National Academy of Sciences·2004· 153 citedOpen Access
HCV core antigen as an alternative to NAT to detect HCV viremia
Transfusion·2004· 7 cited
Sensitivity and reproducibility of HCV quantitation in chimpanzee sera using TaqMan real-time PCR assay
Journal of Virological Methods·2002· 45 cited
Assessment of Markers of Hepatitis C Virus Infection in a Japanese Adult Population
The Journal of Infectious Diseases·2001· 5 citedOpen Access
Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses
Transfusion·2000· 33 cited
Summary of a Food and Drug Administration workshop on nucleic acid testing to screen donations of blood and plasma for the hepatitis C virus
Transfusion·1999· 3 cited
Untitled
JAMA·1997
page 1 of 2Next →

Frequent Co-authors

Stephen M. Feinstone(4), Bobby L. Mason(4), Edward Tabor(4), Kathleen Mihalik(3), Harvey J. Alter(3), Maria Luisa Virata‐Theimer(3), Robert S. Lindsay(3), Zheng-ping Guo(2), Robert H. Purcell(2), Maria Luisa Virata(2), Chuan-Ging Wu(2), Yansheng Geng(2), Montserrat Puig(2), Mahmood Farshid(2), Indira Hewlett(2), Jay S. Epstein(2), Akihiko Okayama(2), Michinori Kohara(2), Nancy Müeller(2), Hirohito Tsubouchi(2)